Correction: Intravenous ferric chloride hexahydrate supplementation induced endothelial dysfunction and increased cardiovascular risk among hemodialysis patients (PLoS ONE)
Journal
PLoS ONE
Journal Volume
8
Journal Issue
5
Date Issued
2013
Author(s)
Abstract
The association between intravenous (IV) iron administration and outcomes in hemodialysis (HD) patients is still debated. Therefore, this study was aimed to assess the relationship between the IV administration of ferric chloride hexahydrate (AtofenH) and cardiovascular (CV) outcome and the interaction between iron-induced oxidative stress and endothelial dysfunction in chronic HD patients.
SDGs
Publisher
Public Library of Science
Type
corrigendum